HLA-G and ovarian neoplasm: Evidence has recently been reported that HIF-1 may act as a negative regulator of HLA-G expression in some human melanoma (FON) and choriocarcinoma (JEG-3) cell lines [22] The functional significance of the methylation of the CpG island surrounding the HIF-1 binding site in the ovarian tumor samples remains to be determined.